FDA Approved: NAPHCON A — Supplemental Application (Alcon Laboratories, Inc.)

View source ↗

Summary

FDA approved a supplemental application for NAPHCON A (naphazoline hydrochloride and pheniramine maleate) by Alcon Laboratories, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• NAPHCON A (Naphazoline hydrochloride and pheniramine maleate)

Snippet

SUPPL AP for NAPHCON A (NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE)